# Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose

> **NCT02494492** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 18 (estimated)

## Conditions studied

- Uveitis

## Interventions

- **OTHER:** intravitreous administration of regulator T-cells

## Key facts

- **NCT ID:** NCT02494492
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2013-03
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2017-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02494492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02494492, "Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02494492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*